hard to know about funding - i wouldn't expect them to have enough cash to cover a 14 day trial (and the subsequent data evaluation) or a HIV trial so they need to co-fund these or capital raise (gotta get that sp up!). taking nothing away from the results, they were first class and if they can push ahead with the 14 day trial, they will almost certainy be partnering up for phase 3 as BIT-225 has, in oil and gas terms, been "derisked".
great result from biotron, page-6
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.18M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.8¢ | $1.335K | 34.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1131315 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 330372 | 2 |
View Market Depth
| Last trade - 15.04pm 09/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |